Insulin Aspart Injection
Active substance: insulin aspart
insulin aspart
Centralised EU authorisationActive
Marketing holder: Masuu Pharma Europe Limited
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 2
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| US 35 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2e94-79aa-9d60-14ad9e26da0b,01a1208c-3b3a-79c6-98b0-f7b37b3d1cc8,01a1208c-5c4e-7624-b125-865afb269ecd,01a1208c-5d5f-7a97-a18c-6e87a32e2935,01a1208c-5d61-78ac-a26d-0074fb92e5d6;count=35 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/006720
- Registration status
- Active
- ATC code
- A10AB05
Sources
- product · EMA · EMEA/H/C/006720 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/006720 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/006720 · Verified 2026-10-09